Nanoco Group PLC - Interim Results
NANOCO GROUP PLC
("Nanoco", the "Company" or the "Group")
Interim Results
Focused on maximising value
Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from its technology platform, announces its unaudited interim results for the half year ended
Continued commercial progress
· Continue to achieve all milestones in the Joint Development Agreement ("JDA") with the first Asian Chemical Customer - now set to finalise R&D in Quantum Dot ("QD") image sensors and transition to scale up phase over the next few months
· JDA with second Asian Chemical Customer achieved positive results, and we are currently in discussions around a further JDA
· Completed the Innovate
· Continue to engage with a number of other customers in different applications of quantum dots, such as Short-Wave Infrared ("SWIR"), Mid-Wave Infrared ("MWIR") and display across
Forecast growth in key markets provides an opportunity
· Our progress on second generation sensing materials, in collaboration with our customers, demonstrates that our quantum dot materials are achieving market-leading device metrics, positioning Nanoco as a key partner in an emerging growth market
· Market sector forecasts1 continue to indicate significant growth in our key market of sensing
· Other markets continue to assess the opportunity to work with quantum dots in their products, which may offer significant opportunity over the long term
· We continue to progress as a research-led production company, with the ambition of becoming cash breakeven in the medium term
Achieving value from our IP portfolio
· We announced a no-fault settlement agreement with LG Electronics for a gross amount
· Settled litigation with Shoei Chemical Inc. and Shoei Electronic Materials, Inc. (collectively, "Shoei"), following Shoei's initial filing of the lawsuit against Nanoco and our counterclaims for infringement and damages
Further reductions in cost base to preserve value
· Further reorganisation completed, including a reduction in the Board's size and cost - gross cash cost base reduced to between
· We have also reduced the footprint of our manufacturing facility in
· We continue to monitor our cost base to assess whether further reductions can be made
Discontinuation of the potential divestment of the Group's trading business
· Following a comprehensive process, no firm offers were received for the potential sale of the trading business, and the Board is no longer seeking a buyer for the trading subsidiary. Instead, we are investing in high-potential organic prospects, while retaining a focus on minimising and reducing the Group's operating expenses.
Results overview
Financial summary
· Reported revenue increased to
· As a result of the increase in revenue, Adjusted EBITDA is significantly ahead of prior year at
· Period end reported cash of
Full year outlook
· Two JDA customers signed up, with potential for further JDAs and product revenues - full year revenue expected to be c.
· Cash at
· Cost base has undergone a significant reduction, with post-restructuring gross annual cash costs expected to be c.
· The Board continues to assess all options to deliver the best outcome for all stakeholders
"The past six months have been constructive for Nanoco, with the JDA with our first Asian Chemical Customer continuing to progress and our focus remaining on developing and scaling the materials over the next couple of years. We are also in discussions regarding a potential extension to the JDA with the second Asian Chemical Customer.
Alongside this, we remain engaged with a number of other potential customers; while these discussions are at an early stage, they could over time contribute to additional revenues and a broader product portfolio.
We have also reduced our cost base significantly, preserving shareholder value while pursuing our organic prospects with our core operational capabilities and IP. We successfully negotiated a licence agreement with LG Electronics, receiving a lump sum payment in the year, and also settled the litigation with Shoei.
1 Sources: Yole, IDTechEx
2 The revenue forecast for FY26 is
For further information, please contact:
Nanoco Group plc:
Liam Gray, Interim CEO & Company Secretary
Sodali & Co
Elly Williamson +44 (0)79 3535 1934
Pete Lambie
Oliver Banks
Cavendish Capital Markets Limited (Financial Adviser and Corporate Broker):
Ed Frisby / George Lawson (Corporate Finance) +44 (0) 20 7220 0500
Ella Bedford (Corporate Broking)
Jasper Berry (Sales)
Notes for editors:
About Nanoco Group plc
Nanoco (LSE: NANO) is a nanomaterial production and licensing group, specialising in the production of its patented cadmium free quantum dots (CFQD®) and other patented nanomaterials for use in the electronics industries. Founded in 2001 and headquartered in Runcorn, UK, Nanoco continues to build out a world-class, patent-protected IP portfolio alongside its existing scaled up production facilities for commercial orders.
Nanomaterials are materials with dimensions typically in the range 1 - 100 nm. Nanomaterials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nanomaterial that have size-dependent optical and electronic properties. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Sensor, Electronics and Display markets. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of display applications. Nanoco's HEATWAVE™ quantum dots can be tuned to absorb light at different wavelengths across the near-infrared spectra, rendering them useful for applications including cameras and image sensors.
Nanoco is listed on the Main Market of the London Stock Exchange, holds the LSE's Green Economy Mark, and trades under the ticker symbol NANO. For further information please visit: www.nanocotechnologies.com
Business Review
Company lean and focused on delivering for our key market
During the Period, the Board continued to execute its previously announced strategy, with key developments being;
· Continued focus on quantum dots for the image sensor market, with two key customers pushing developments in this area;
· A successful outcome from the LG litigation;
· A significant reduction in the Group's cost base to minimise cash burn and focus on commercial growth.
In addition to the two main customers in image sensing, the Company continues to engage with a number of other customers across a variety of applications on potential collaborations and JDAs. The increasing revenues, coupled with the reduction in the cost base, mean Nanoco is on track to achieve its target of breakeven in the medium term.
Sensing
As announced in
We have also delivered on all milestones for the second Asian Chemical Customer. We are currently in discussions around a further extension to this JDA.
In addition, we continue to work with a number of other customers on potential JDAs or material supply. This has recently extended to doing some exploratory work on MWIR to develop a working prototype to test the capabilities of such a device.
Display
We continue to engage with several Asian companies involved in existing Liquid Crystal Display ("LCD") technologies. Due to the continuing trend of substituting cadmium ("Cd") based products with Cd-free alternatives, we see an opportunity to introduce Nanoco Cd-free QDs into these established supply chains. Our engagement is at different points of the supply chain, including both display manufacturers and component (QD film) makers.
Operations
As announced on
We have also served notice on a number of locations on site and are in the process of vacating these premises. The reduced floor space reduces the quantity of PbS quantum dots that can be produced, but we can still scale up and manufacture significant volumes in the remaining facilities of both PbS and InAs quantum dots.
Our device lab continues to provide timely feedback on the quantum dots being developed, and our capabilities in device continue to expand and be recognised by customers who wish to use our equipment for their testing and feedback.
IP Licensing
Our primary goal for Nanoco is the development, scale up and commercial production of nanomaterials. Our IP portfolio is primarily used to support those objectives. However, where we believe our IP is being used without a licence, we will pursue for damages. This was evidenced in our successful licence agreement with LG, who agreed to pay
In
The CDX Process
The Board had been exploring the potential sale of the trading subsidiary. Whilst the outreach and engagement had been positive, ultimately the Board believed there was greater value for shareholders in the organic prospects of the business. Therefore, the formal outreach from Nanoco was cancelled in
The Board continues to evaluate strategic options to deliver the best outcome for all stakeholders.
Board
As announced on
Outlook - solid foundation for organic success
Market sector forecasts1 continue to support strong growth for SWIR sensors and quantum dot-based display technologies over the next five years. In combination with other QD market segments, the Company estimates an approximately
In the Image Sensor market, we are seeing a strong trend towards heavy metal-free materials, particularly in the automotive and consumer electronics applications. Industrial and defence-based applications are more willing to compromise on the materials, which provides a short-term opportunity for our first generation PbS materials.
These trends position Nanoco to grow its product revenues, with further growth coming from other applications of quantum dots that require longer development.
Liam Gray
Interim Chief Executive Officer
1 Sources: Yole, IDTechEx
Statement regarding Shareholder Consultation following the 2025 Annual General Meeting
At the Nanoco Group Plc Annual General Meeting ("AGM") held on
Consequently, in accordance with the UK Corporate Governance Code, the Company engaged with a number of larger shareholders to solicit their feedback on voting at the AGM, in particular on the resolutions referenced above. The majority of shareholders we reached out to confirmed they had voted in favour of these resolutions. The Board would like to thank all shareholders that engaged in the process.
Financial review
Revenue
Reported revenue in the Period increased 123% to
|
Sources of revenue |
H1 FY26 |
H1 FY25 |
FY25 |
|
|
£m |
£m |
£m |
|
Services |
0.8 |
0.3 |
1.2 |
|
Material sales |
0.1 |
0.1 |
0.1 |
|
Licences |
6.8 |
3.0 |
6.3 |
|
Total revenue |
7.7 |
3.4 |
7.6 |
Excluding the licence revenue, services revenues continue to be the major revenue driver, primarily from the two JDAs. The increase on H1 FY25 is due to the second JDA which commenced in the prior year. Material sales represent shipments of nanomaterials to supply chain partners in sensing and display markets.
Operating expenses
Operating expenses comprise R&D and administrative expenses. Gross investment in R&D to support the ongoing development of our nanomaterials was
Operating profit and adjusted EBITDA
The increased revenue in the Period directly impacted adjusted operating profit in the Period, increasing to a
|
|
H1 FY26 |
H1 FY25 |
FY25 |
|
|
£m |
£m |
£m |
|
Operating profit/(loss) |
2.5 |
(1.2) |
(1.6) |
|
Requisitioned general meeting |
- |
0.2 |
0.2 |
|
Strategic review fees |
0.1 |
0.2 |
0.3 |
|
Restructuring costs |
0.1 |
0.1 |
0.1 |
|
Litigation costs |
1.2 |
- |
0.3 |
|
Foreign exchange |
0.1 |
- |
- |
|
Share-based payment charge |
0.1 |
0.5 |
0.7 |
|
Employers NI on SBP |
0.0 |
0.0 |
0.1 |
|
Adjusted operating profit/(loss) |
4.1 |
(0.2) |
0.1 |
|
Depreciation |
0.8 |
0.6 |
1.2 |
|
Amortisation |
0.1 |
0.1 |
0.1 |
|
Impairment |
0.1 |
0.0 |
0.1 |
|
Adjusted EBITDA |
5.1 |
0.5 |
1.5 |
Management monitor Adjusted EBITDA as an Alternative Performance Measure. The non-cash charges for share-based payments (including the associated national insurance charges), depreciation and amortisation are added back to the operating result to arrive at Adjusted EBTIDA. One-off cash costs are also excluded from Adjusted EBITDA. These items are excluded to provide users of the accounts with a clearer understanding of underlying business performance.
Taxation
A deferred tax asset for brought forward losses expected to be utilised in future years was recognised in FY24 and remains at the period end. The Korean withholding tax on the Samsung licence agreement creates a UK tax asset of
Net result
The profit after tax for H1 FY26 was
Earnings per share
The basic profit per share was
Cash position and liquidity
Following the receipt of LG licence income the Group had a cash balance at
Working capital
Our contracts with customers include mechanisms to give Nanoco advance notice of significant changes in demand that should be adequate to ensure that Nanoco has appropriate raw materials on hand when production needs to be ramped up.
Principal risks
The Directors have considered the principal risks which may have a material impact on the Group's performance. The majority of applicable risks throughout the Period remained materially unchanged to those as disclosed on pages 33 to 35 of the 2025 Annual Report and Accounts.
Going concern
The interim condensed consolidated financial statements have been prepared on a going concern basis. In determining the appropriate basis of preparation of the financial statements, the Directors are required to consider whether the Group can continue in operational existence for the foreseeable future.
For the purposes of assessing whether 'going concern' is an appropriate basis for preparing the interim condensed consolidated financial statements, the Directors have used their detailed forecasts for the period to
A sensitivity analysis has been performed to reflect a possible downside scenario that only includes already contracted revenues for the Forecast Period.
On the basis of the information above and having made appropriate enquiries, at the time of approving the interim condensed consolidated financial statements, the Directors have a reasonable expectation that the Company has access to adequate resources to continue in operational existence for the foreseeable future, at least 12 months from the date of the issue of these interim condensed consolidated financial statements.
Accordingly, they continue to adopt the going concern basis in preparing the interim condensed consolidated financial statements. The financial statements do not reflect any adjustments that would be required to be made if they were prepared on a basis other than the going concern basis.
Liam Gray
Interim Chief Executive Officer
Responsibility statement
The Directors of Nanoco Group plc, as listed on pages 50 and 51 of the 2024 Annual Report and Accounts, excluding Dr Dmitry Shashkov and Dr Nigel Pickett who have both left the business, confirm to the best of their knowledge:
a) the interim condensed consolidated financial statements have been prepared in accordance with International Accounting Standard 34 Interim Financial Reporting, as required by paragraph 4.2.4 of the Disclosure Guidance and Transparency Rules ("DTR");
b) the interim condensed consolidated financial statements, which have been prepared in accordance with the applicable set of accounting standards, give a true and fair view of the assets, liabilities, financial position and profit or loss of the issuer, or the undertakings included in the consolidation as a whole as required by DTR 4.2.10;
c) the interim management report includes a fair review of the information required by DTR 4.2.7 - an indication of important events which have occurred during the first six months of the year and a description of the principal risks and uncertainties for the remaining six months of the year; and
d) the interim management report includes a fair review of the information required by DTR 4.2.8 - the disclosure of related party transactions occurring during the first six months of the year and any changes in related party transactions disclosed in the 2025 Annual Report and Accounts.
By order of the Board
Liam Gray
Interim Chief Executive Officer
Condensed consolidated statement of comprehensive income
For the six months ended
|
|
|
H1 FY26 |
H1 FY25 |
FY25 |
|
|
|
(Unaudited) |
(Unaudited) |
(Audited) |
|
|
Notes |
£'000 |
£'000 |
£'000 |
|
|
|
|
|
|
|
Revenue |
3 |
7,700 |
3,448 |
7,618 |
|
Cost of sales |
|
(379) |
(259) |
(622) |
|
Gross profit |
|
7,321 |
3,189 |
6,996 |
|
Other operating income |
|
|
|
|
|
Government grants |
|
45 |
8 |
8 |
|
Operating expenses |
|
|
|
|
|
Research and development expenses |
|
(903) |
(741) |
(1,349) |
|
Administrative expenses |
|
(3,949) |
(3,705) |
(7,267) |
|
Operating profit/(loss) |
|
2,514 |
(1,249) |
(1,612) |
|
- Before share-based payments and non-recurring items |
|
3,973 |
(296) |
27 |
|
- Share-based payments |
|
(63) |
(458) |
(731) |
|
- Strategic review fees |
|
(76) |
(210) |
(313) |
|
- Litigation costs |
|
(1,192) |
- |
(255) |
|
- EGM requisition costs |
|
|
(211) |
(230) |
|
- Capital reduction fees |
|
- |
- |
(37) |
|
- Restructuring costs |
|
(128) |
(74) |
(73) |
|
Finance income |
|
234 |
339 |
731 |
|
Finance expense |
|
(34) |
(50) |
(92) |
|
Profit/(loss) before taxation |
|
2,714 |
(960) |
(973) |
|
Taxation |
|
(458) |
(74) |
(1,224) |
|
Profit/(loss) after tax |
|
2,256 |
(1,034) |
(2,197) |
|
Other comprehensive income |
|
|
|
|
|
Loss on exchange rate translations |
|
(3) |
(7) |
(6) |
|
Total comprehensive profit/(loss) for the year |
|
2,253 |
(1,041) |
(2,203) |
|
Earnings/(loss) per share: |
|
|
|
|
|
Basic earnings/(loss) |
4 |
1.15p |
(0.53p) |
(1.13p) |
|
Diluted earnings/(loss) |
4 |
1.10p |
(0.53p) |
(1.13p) |
|
|
|
|
|
|
The (Loss)/profit for the current and preceding year arise from the Group's continuing operations and is attributable to the equity holders of the Parent Company.
The basic and diluted loss per share reported in H1 FY25 and FY25 are the same, as the effect of share options is anti-dilutive.
Condensed consolidated statement of changes in equity
For the six months ended
|
|
|
Capital |
|
Reverse |
Share-based |
|
Shares |
|
|
|
|
Share |
Redemption |
Share |
acquisition |
payment |
Merger |
held |
Accumulated |
|
|
|
capital |
Reserve |
Premium |
reserve |
reserve |
reserve |
by EBT |
loss |
Total |
|
|
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
|
At |
20,257 |
12,186 |
- |
(77,868) |
1,572 |
(1,242) |
(3,348) |
31,432 |
(17,011) |
|
Loss for the six months to |
- |
- |
- |
- |
- |
- |
- |
(1,041) |
(1,041) |
|
Share buy-back |
(796) |
796 |
- |
- |
- |
- |
28 |
(1,045) |
(1,017) |
|
Exercise of share options |
- |
- |
- |
- |
(233) |
- |
158 |
75 |
- |
|
Share-based payments |
- |
- |
- |
- |
458 |
- |
- |
- |
458 |
|
At |
19,461 |
12,982 |
- |
(77,868) |
1,797 |
(1,242) |
(3,162) |
29,421 |
(18,611) |
|
Loss for the six months to |
- |
- |
- |
- |
- |
- |
- |
(1,162) |
(1,162) |
|
Share buy-back |
- |
- |
- |
- |
- |
- |
- |
(6) |
(6) |
|
Capital reduction |
- |
(12,186) |
- |
- |
- |
- |
- |
12,186 |
- |
|
Transfer of expired options |
- |
- |
- |
- |
(380) |
- |
- |
380 |
- |
|
Share-based payments |
- |
- |
- |
- |
273 |
- |
- |
- |
273 |
|
At |
19,461 |
- |
- |
(77,868) |
1,690 |
(1,242) |
(3,162) |
41,615 |
(19,506) |
|
Profit for the six months to |
- |
- |
- |
- |
- |
- |
- |
2,253 |
2,253 |
|
Share issue |
94 |
- |
7 |
- |
(101) |
- |
- |
- |
- |
|
Exercise of share options |
- |
- |
- |
- |
(118) |
- |
139 |
(21) |
- |
|
Share-based payments |
- |
- |
- |
- |
63 |
- |
- |
- |
63 |
|
At |
19,555 |
- |
7 |
(77,868) |
1,534 |
(1,242) |
(3,023) |
43,847 |
(17,190) |
Condensed consolidated statement of financial position
As at
|
|
|
31 January |
31 January |
31 July |
|
|
|
2026 |
2025 |
2025 |
|
|
|
(Unaudited) |
(Unaudited) |
(Audited) |
|
|
Notes |
£'000 |
£'000 |
£'000 |
|
Assets |
|
|
|
|
|
Non-current assets |
|
|
|
|
|
Tangible fixed assets |
|
1,280 |
1,652 |
1,492 |
|
Right of use assets |
|
675 |
1,827 |
1,452 |
|
Intangible assets |
|
454 |
683 |
600 |
|
Deferred tax asset |
|
1,599 |
2,350 |
1,599 |
|
Foreign withholding tax receivable |
|
704 |
1,590 |
780 |
|
|
|
4,712 |
8,102 |
5,923 |
|
Current assets |
|
|
|
|
|
Inventories |
|
131 |
168 |
165 |
|
Trade and other receivables |
|
772 |
1,010 |
670 |
|
Foreign withholding tax receivable |
|
152 |
149 |
152 |
|
Income tax asset |
|
319 |
235 |
319 |
|
Cash and cash equivalents |
|
14,365 |
15,484 |
13,998 |
|
|
|
15,739 |
17,046 |
15,304 |
|
Total assets |
|
20,451 |
25,148 |
21,227 |
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
Current liabilities |
|
|
|
|
|
Trade and other payables |
|
(1,992) |
(943) |
(1,495) |
|
Lease liabilities |
6 |
(545) |
(693) |
(643) |
|
Deferred revenue |
5 |
(6,075) |
(5,944) |
(6,090) |
|
|
|
(8,612) |
(7,580) |
(8,228) |
|
Non-current liabilities |
|
|
|
|
|
Lease liabilities |
6 |
(217) |
(917) |
(655) |
|
Provisions |
|
(669) |
(659) |
(669) |
|
Deferred revenue |
5 |
(28,143) |
(34,603) |
(31,181) |
|
|
|
(29,029) |
(36,179) |
(32,505) |
|
Total liabilities |
|
(37,641) |
(43,759) |
(40,733) |
|
|
|
|
|
|
|
Net (liabilities)/assets |
|
(17,190) |
(18,611) |
(19,506) |
|
|
|
|
|
|
|
Capital and reserves |
|
|
|
|
|
Share capital |
|
19,555 |
19,461 |
19,461 |
|
Capital redemption reserve |
|
- |
12,982 |
- |
|
Share Premium |
|
7 |
- |
- |
|
Reverse Acquisition Reserve |
|
(77,868) |
(77,868) |
(77,868) |
|
Share-based payment reserve |
|
1,534 |
1,797 |
1,690 |
|
Merger reserve |
|
(1,242) |
(1,242) |
(1,242) |
|
Shares held by EBT |
|
(3,023) |
(3,162) |
(3,162) |
|
Accumulated profit/(loss) |
|
43,847 |
29,421 |
41,615 |
|
Total equity |
|
(17,190) |
(18,611) |
(19,506) |
Approved by the Board and authorised for issue on
Liam Gray
Interim Chief Executive Officer
Condensed consolidated cash flow statement
For the six months ended
|
|
|
Six months to |
Six months to |
Year to |
|
|
|
31 January |
31 January |
31 July |
|
|
|
2026 |
2025 |
2025 |
|
|
|
(Unaudited) |
(Unaudited) |
Audited |
|
|
|
£'000 |
£'000 |
£'000 |
|
Profit/(loss) before tax |
|
2,714 |
(960) |
(973) |
|
Adjustments for: |
|
|
|
|
|
Net finance income |
|
(200) |
(289) |
(639) |
|
Loss on exchange rate translations |
|
103 |
5 |
37 |
|
Depreciation of tangible fixed assets |
|
211 |
201 |
412 |
|
Depreciation of right of use asset |
|
562 |
376 |
763 |
|
Amortisation of intangible assets |
|
81 |
96 |
189 |
|
Impairment of intangible assets |
|
98 |
2 |
51 |
|
Share-based payments |
|
63 |
458 |
731 |
|
(Profit) / loss on disposal of tangible fixed assets |
|
25 |
- |
25 |
|
Increase/(decrease) in inventory provision |
|
|
150 |
78 |
|
Changes in working capital: |
|
|
|
|
|
Decrease/(increase) in inventories |
|
34 |
(13) |
62 |
|
(Increase)/decrease in trade and other receivables |
|
(102) |
73 |
413 |
|
Increase/(decrease) in trade and other payables |
|
497 |
(635) |
(83) |
|
Decrease in deferred revenue |
|
(3,053) |
(2,981) |
(6,257) |
|
Cash inflow/(outflow) from operating activities |
|
1,033 |
(3,517) |
(5,191) |
|
Foreign withholding tax paid |
|
(382) |
- |
- |
|
Research and development tax credit received |
|
- |
- |
325 |
|
Net cash outflow from operating activities |
|
651 |
(3,517) |
(4,866) |
|
|
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
|
Purchases of tangible fixed assets |
|
(24) |
(203) |
(282) |
|
Purchases of intangible fixed assets |
|
(33) |
(38) |
(95) |
|
Proceeds from sale of tangible fixed assets |
|
- |
- |
4 |
|
Interest received |
|
234 |
339 |
731 |
|
Net cash outflow from investing activities |
|
177 |
98 |
358 |
|
|
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
|
Return of capital to shareholders |
|
- |
(1,010) |
(1,009) |
|
Fees on return of capital to shareholders |
|
- |
(7) |
(14) |
|
Payment of lease liabilities (capital) |
|
(321) |
(314) |
(627) |
|
Payment of lease liabilities (interest) |
|
(31) |
(48) |
(87) |
|
Interest paid |
|
(3) |
(3) |
(6) |
|
Net cash outflow from financing activities |
|
(355) |
(1,382) |
(1,743) |
|
|
|
|
|
|
|
Increase / (Decrease) in cash and cash equivalents |
|
473 |
(4,801) |
(6,251) |
|
Cash and cash equivalents at the start of the period |
|
13,998 |
20,293 |
20,293 |
|
Effects of exchange rate changes |
|
(106) |
(8) |
(44) |
|
Cash and cash equivalents at the end of the period |
|
14,365 |
15,484 |
13,998 |
Notes to the interim condensed consolidated financial statements
For the six months ended
1. Corporate information
Nanoco Group plc (the "Company"), a public company limited by shares, is on the equity shares (commercial companies) list of the London Stock Exchange and is incorporated and domiciled in the UK. The Group Interim Report and Accounts for the six months ended
These interim condensed consolidated financial statements include the financial statements of Nanoco Group plc and the entities it controls (its subsidiaries).
These interim condensed consolidated financial statements are unaudited and do not constitute statutory accounts of the Group as defined in section 434 of the Companies Act 2006.
2. Accounting policies
a. Basis of preparation
These interim condensed consolidated financial statements have been prepared in accordance with the Disclosure and Transparency Rules of the Financial Conduct Authority, UK-adopted IAS 34 Interim Financial Reporting, using the recognition and measurement principles of UK-adopted IFRS and have been prepared under the historical cost convention. As required by the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority the accounting policies adopted in these condensed consolidated financial statements are consistent with those followed in the preparation of the Group's Annual Report and Accounts for the year to
These interim condensed consolidated financial statements include audited comparatives for the year to
b. Presentation of figures
Certain figures contained in this announcement, including financial information, have been subject to rounding adjustments. Accordingly, in some cases, the sum or percentage change of the numbers contained in this announcement may not conform exactly to the total figure given.
c. Going concern
The interim condensed consolidated financial statements have been prepared on a going concern basis as set out in the Financial Review section.
d. Use of estimates and judgements
Preparation of the interim condensed consolidated financial statements requires management to make judgements, estimates and assumptions affecting the application of accounting policies and the reporting of assets, liabilities, income and expenses. Actual results may differ from these estimates. The significant judgements made by management in applying the Group's accounting policies and key sources of estimated uncertainty were the same as those applied to the consolidated financial statements for the year ended 31 July 2025. These are summarised below:
|
Estimates |
Judgements |
|
Period over which to amortise Samsung licence |
Revenue recognition |
|
Equity-settled share-based payments |
Samsung licence of IP |
|
Deferred tax |
Capitalisation (or not) of research and development expenditure |
3. Segmental information
Operating segments
At 31 January 2026 and 2025, the Group operated as one segment, being the research, development and manufacture of products and services based on high performance nanoparticles. This is the level at which operating results are reviewed by the chief operating decision maker (i.e. the Board) to make decisions about resources, and for which financial information is available. All revenues have been generated from continuing operations and are from external customers.
|
|
|
Six months to 31 January 2026 |
Six months to 31 January 2025 |
Year to 31 July 2025 |
|
|
|
(Unaudited) |
(Unaudited) |
(Audited) |
|
|
|
£'000 |
£'000 |
£'000 |
|
Analysis of revenue - by type |
|
|
|
|
|
Products sold |
|
42 |
60 |
131 |
|
Rendering of services |
|
816 |
416 |
1,215 |
|
Licences |
|
6,842 |
2,972 |
6,272 |
|
|
|
7,700 |
3,448 |
7,618 |
There were two material customers who generated product and service revenue of £848,000 (2025: two material customers amounting to £442,000). £3,037,000 of the licence revenue related to the Samsung licence (2025: £2,972,000) and £3,806,000 related to LG Electronics.
The Group operates in a number of countries across the world, although all are managed in the UK. The Group's revenue per country based on the customer's location is as follows:
|
|
|
Six months to 31 January 2026 |
Six months to 31 January 2025 |
Year to 31 July 2025 |
|
|
|
(Unaudited) |
(Unaudited) |
(Audited) |
|
|
|
£'000 |
£'000 |
£'000 |
|
Analysis of revenue - by geography |
|
|
|
|
|
South Korea |
|
6,842 |
2,972 |
6,272 |
|
Japan |
|
849 |
268 |
810 |
|
Netherlands |
|
- |
174 |
492 |
|
UK |
|
1 |
34 |
34 |
|
France |
|
- |
- |
9 |
|
Belgium |
|
4 |
- |
1 |
|
China |
|
2 |
- |
- |
|
Canada |
|
1 |
- |
- |
|
Spain |
|
1 |
- |
- |
|
|
|
7,700 |
3,448 |
7,618 |
All the Group's assets are held in the UK and all of its capital expenditure arises in the UK. The profit before taxation and attributable to the single segment was £2,714,000 (2025: £960,000 profit).
4. Earnings per share
|
|
|
Six months to 31 January 2026 |
Six months to 31 January 2025 |
Year to 31 July 2025 |
|
|
|
(Unaudited) |
(Unaudited) |
(Audited) |
|
|
|
£'000 |
£'000 |
£'000 |
|
Profit/(loss) for the period attributable to equity shareholders |
2,253 |
(1,041) |
(2,203)
|
|
|
Share-based payments |
63 |
458 |
731 |
|
|
Profit/(loss) for the period before share-based payments |
|
2,316 |
(583) |
(1,472) |
|
|
|
|
|
|
|
Weighted average number of shares |
|
No. |
No. |
No. |
|
Ordinary shares in issue |
|
195,289,529 |
196,522,718 |
195,615,212 |
|
Options exercisable at the reporting date |
|
1,754,872 |
990,407 |
4,021,999 |
|
Options not yet exercisable at the reporting date |
|
7,323,453 |
15,649,778 |
10,732,098 |
|
Diluted weighted average number of shares |
|
204,367,854 |
213,162,903 |
210,369,309 |
|
Adjusted profit/(loss) per share before share-based payments (pence) |
1.18 |
(0.30) |
(0.75) |
|
|
Basic profit/(loss) per share (pence) |
|
1.15 |
(0.53) |
(1.13) |
|
Diluted adjusted profit/(loss) per share before share-based payments (pence) |
|
1.13 |
(0.30) |
(0.75) |
|
Diluted profit/(loss) per share (pence) |
|
1.10 |
(0.53) |
(1.13) |
Diluted loss per share is not presented for the 6 months to January 2025 and the year to July 2025 as the effect of share options issued is anti-dilutive. The adjusted loss is presented as the Board measures underlying business performance which excludes non-cash IFRS2 charges.
5. Deferred revenue
|
|
|
31 January 2026 |
31 January 2025 |
31 July 2025 |
|
|
|
(Unaudited) |
(Unaudited) |
(Audited) |
|
|
|
£'000 |
£'000 |
£'000 |
|
Current |
|
|
|
|
|
Upfront licence fees |
|
6,075 |
5,944 |
6,075 |
|
Contract liability on JDA |
|
- |
- |
15 |
|
Total current |
|
6,075 |
5,944 |
6,090 |
|
Non-current |
|
|
|
|
|
Upfront licence fees |
|
28,143 |
34,603 |
31,181 |
|
Total non-current |
|
28,143 |
34,603 |
31,181 |
|
|
|
|
|
|
|
Total deferred revenue |
|
34,218 |
40,547 |
37,271 |
Deferred revenue arises under IFRS where upfront licence fees are accounted for on a straight-line basis over the initial term of the contract or where performance criteria have not been satisfied in the accounting period.
6. Lease liabilities
|
|
|
31 January 2026 |
31 January 2025 |
31 July 2025 |
|
|
|
(Unaudited) |
(Unaudited) |
(Audited) |
|
|
|
£'000 |
£'000 |
£'000 |
|
Current |
|
|
|
|
|
Property Leases |
545 |
691 |
642 |
|
|
Equipment leases |
- |
2 |
1 |
|
|
Non-current |
|
|
|
|
|
Property Leases |
|
217 |
917 |
655 |
|
Equipment leases |
|
- |
- |
- |
|
Total lease liabilities |
|
762 |
1,610 |
1,298 |
7. Post Balance Sheet Event
As announced on 26 March 2026, the Company entered into a definitive agreement with Shoei Chemical Inc. and Shoei Electronic Materials, Inc. (collectively, "Shoei") to settle the ongoing litigation. Costs incurred between December 2025 and March 2026 relating to this litigation amounted to £3.2m.
- Ends -
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE